We observed maximal stimulation of cell proliferation and inhibition of apoptosis in response to genistein in LNCaP cells at a dose of 1μmol/L, indicating that apparently modest exposure to the phytoestrogen genistein can have significant adverse biological consequences for prostate cancers that carry promiscuously mutant AR. This evidence concerns the gene AR and prostate carcinoma.